ArticleNature communications2022

Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC.

Robert Saddawi-Konefka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.